Platform
Features
Pricing
2 followers
Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.
Industries
Headquarters
Employees
Links
Kenneth Galbraith
53 members
18 members
6 members
14 members
9 members
View all
CRISPR Therapeutics
9 followers
Arrowhead Pharmaceuticals
4 followers
Cerus
Wealthsimple
79 followers
Vena Solutions
StackAdapt
33 followers
Telesat
Thermo Fisher Scientific
155 followers
Agilent Technologies
63 followers
CSL
40 followers
Myriad Genetics
35 followers
Explore companies